Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Consumer Staples Select Sector SPDR Fund — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Consumer Staples Select Sector SPDR Fund trades at $87.4 (market cap $14.73B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2.1× Consumer Staples Select Sector SPDR Fund's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Consumer Staples Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| GEHC | XLP | |
|---|---|---|
Market Cap | $30.93B | $14.73B |
Volume | 5,033,451 | 14,288,954 |
Sector | Health | — |
52-Week High | $88.16 | $90.00 |
52-Week Low | $59.48 | $75.61 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 73 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
XLP trades at $84.19, down 0.26% on the day, with strong technical momentum showing a bullish moving average signal despite an overbought RSI reading. The ETF maintains 100% analyst buy ratings and recently announced a $0.54 dividend payable in September 2026. Consumer staples sector performance has been resilient, with XLP gaining 6.6% year-to-date while outperforming discretionary counterparts by over 13 percentage points.
The defensive nature of consumer staples provides stability amid market volatility, though elevated interest rates pose a headwind. With strong technical momentum and unanimous analyst support, XLP offers defensive exposure with dividend income potential, but investors should monitor inflation pressures and consumer spending trends that could impact sector performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
